US OptionsDetailed Quotes
PFE240726C25000
- 5.35
- +1.05+24.42%
15min DelayClose Jul 25 15:59 ET
5.50High5.35Low
5.50Open4.30Pre Close262 Volume11 Open Interest25.00Strike Price141.17KTurnover392.05%IV0.56%PremiumJul 26, 2024Expiry Date5.18Intrinsic Value100Multiplier0DDays to Expiry0.17Extrinsic Value100Contract SizeAmericanOptions Type0.8881Delta0.0379Gamma5.51Leverage Ratio-0.7248Theta0.0004Rho4.90Eff Leverage0.0024Vega
Pfizer Stock Discussion
PFE us at resistance, 30.70
Earnings soon, stars aligned
above 50 EMA
When PFE turns, it will move hard and fast. a lot of pressure has been built up over the 1.5-year drop.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US)$ , adding a layer of clout to the R&D behind the prospective treatment.
Sneaking on the radar on a red day.
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US)$ $iShares Russell 2000 ETF(IWM.US)$ $MarketAxess(MKTX.US)$ $Pfizer(PFE.US)$ $Vanguard Real Estate ETF(VNQ.US)$ $Global Payments(GPN.US)$
loading...
No comment yet